Kestra Medical Technologies, Ltd.
KMTS
$21.05
$0.64013.14%
| 10/31/2024 | 07/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 189.91% | 189.91% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 189.91% | 189.91% | |||
| Cost of Revenue | 53.20% | 53.20% | |||
| Gross Profit | 623.76% | 623.76% | |||
| SG&A Expenses | 16.50% | 16.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 19.92% | 19.92% | |||
| Operating Income | 16.09% | 16.09% | |||
| Income Before Tax | 18.44% | 18.44% | |||
| Income Tax Expenses | -59.46% | -59.46% | |||
| Earnings from Continuing Operations | 18.47% | 18.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 19.84% | 19.84% | |||
| EBIT | 16.09% | 16.09% | |||
| EBITDA | 16.85% | 16.85% | |||
| EPS Basic | 13.50% | 13.50% | |||
| Normalized Basic EPS | 16.10% | 16.10% | |||
| EPS Diluted | 13.50% | 13.50% | |||
| Normalized Diluted EPS | 16.10% | 16.10% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
